These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB. Wanna-Udom S; Terashima M; Lyu H; Ishimura A; Takino T; Sakari M; Tsukahara T; Suzuki T Biochem Biophys Res Commun; 2020 Mar; 524(1):150-155. PubMed ID: 31982139 [TBL] [Abstract][Full Text] [Related]
4. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis. Zhao C; Ling X; Xia Y; Yan B; Guan Q Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065 [TBL] [Abstract][Full Text] [Related]
5. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer. Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396 [TBL] [Abstract][Full Text] [Related]
6. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471 [TBL] [Abstract][Full Text] [Related]
7. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition. Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987 [TBL] [Abstract][Full Text] [Related]
8. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
9. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z; Li Q; Liu P; Dong W; Zuo Y Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897 [TBL] [Abstract][Full Text] [Related]
10. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881 [TBL] [Abstract][Full Text] [Related]
11. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related]
12. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer. Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897 [TBL] [Abstract][Full Text] [Related]
13. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation. Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744 [TBL] [Abstract][Full Text] [Related]
14. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway. Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701 [TBL] [Abstract][Full Text] [Related]
15. METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome. Shi W; Yang F; Dai R; Sun Y; Chu Y; Liao S; Hao B Front Cell Dev Biol; 2021; 9():621374. PubMed ID: 33869171 [TBL] [Abstract][Full Text] [Related]
16. m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1. Zhou W; Xian Q; Wang Q; Wu C; Yan H; Li X; Lu L; Wu C; Zhu D; Xu X; Wu J J Oncol; 2021; 2021():8875424. PubMed ID: 34394353 [TBL] [Abstract][Full Text] [Related]
17. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner. Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101 [TBL] [Abstract][Full Text] [Related]
18. m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-β-induced epithelial-mesenchymal transition of lung cancer cells. Suphakhong K; Terashima M; Wanna-Udom S; Takatsuka R; Ishimura A; Takino T; Suzuki T J Biol Chem; 2022 Nov; 298(11):102554. PubMed ID: 36183833 [TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1. Dong G; Yu J; Shan G; Su L; Yu N; Yang S Front Cell Dev Biol; 2021; 9():731810. PubMed ID: 34950654 [TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2. Wang H; Xu B; Shi J Gene; 2020 Jan; 722():144076. PubMed ID: 31454538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]